nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—CYP1A2—Carmustine—malignant glioma	0.205	0.57	CbGbCtD
Quinine—CYP3A4—Temozolomide—malignant glioma	0.155	0.431	CbGbCtD
Quinine—Disorder sight—Temozolomide—malignant glioma	0.00804	0.0316	CcSEcCtD
Quinine—Azotaemia—Carmustine—malignant glioma	0.00743	0.0292	CcSEcCtD
Quinine—Quinidine—CYP2B6—malignant glioma	0.00656	1	CrCbGaD
Quinine—Myasthenia—Carmustine—malignant glioma	0.0063	0.0248	CcSEcCtD
Quinine—Aphasia—Carmustine—malignant glioma	0.0061	0.024	CcSEcCtD
Quinine—Aphasia—Temozolomide—malignant glioma	0.0059	0.0232	CcSEcCtD
Quinine—Scotoma—Carmustine—malignant glioma	0.00521	0.0205	CcSEcCtD
Quinine—Hepatotoxicity—Carmustine—malignant glioma	0.00513	0.0202	CcSEcCtD
Quinine—Necrosis—Carmustine—malignant glioma	0.00504	0.0198	CcSEcCtD
Quinine—Scotoma—Temozolomide—malignant glioma	0.00504	0.0198	CcSEcCtD
Quinine—Hepatotoxicity—Temozolomide—malignant glioma	0.00495	0.0195	CcSEcCtD
Quinine—Coagulopathy—Temozolomide—malignant glioma	0.00491	0.0193	CcSEcCtD
Quinine—Petechiae—Temozolomide—malignant glioma	0.00465	0.0183	CcSEcCtD
Quinine—Hearing impaired—Temozolomide—malignant glioma	0.00402	0.0158	CcSEcCtD
Quinine—Coma—Carmustine—malignant glioma	0.00362	0.0142	CcSEcCtD
Quinine—Aplastic anaemia—Temozolomide—malignant glioma	0.00359	0.0141	CcSEcCtD
Quinine—Deafness—Temozolomide—malignant glioma	0.0031	0.0122	CcSEcCtD
Quinine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00294	0.0116	CcSEcCtD
Quinine—Purpura—Temozolomide—malignant glioma	0.00288	0.0113	CcSEcCtD
Quinine—Diplopia—Carmustine—malignant glioma	0.00287	0.0113	CcSEcCtD
Quinine—Diplopia—Temozolomide—malignant glioma	0.00278	0.0109	CcSEcCtD
Quinine—Ataxia—Carmustine—malignant glioma	0.0027	0.0106	CcSEcCtD
Quinine—Liver function test abnormal—Carmustine—malignant glioma	0.00265	0.0104	CcSEcCtD
Quinine—Ataxia—Temozolomide—malignant glioma	0.00261	0.0103	CcSEcCtD
Quinine—Muscular weakness—Carmustine—malignant glioma	0.00253	0.00997	CcSEcCtD
Quinine—Breast disorder—Temozolomide—malignant glioma	0.00251	0.00987	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0025	0.00984	CcSEcCtD
Quinine—Muscular weakness—Temozolomide—malignant glioma	0.00245	0.00963	CcSEcCtD
Quinine—Pancytopenia—Carmustine—malignant glioma	0.00236	0.00928	CcSEcCtD
Quinine—Neutropenia—Carmustine—malignant glioma	0.00232	0.00913	CcSEcCtD
Quinine—Pancytopenia—Temozolomide—malignant glioma	0.00228	0.00897	CcSEcCtD
Quinine—Neutropenia—Temozolomide—malignant glioma	0.00224	0.00883	CcSEcCtD
Quinine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00219	0.00862	CcSEcCtD
Quinine—Renal failure—Carmustine—malignant glioma	0.00218	0.00856	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00212	0.00835	CcSEcCtD
Quinine—Haemoglobin—Carmustine—malignant glioma	0.002	0.00786	CcSEcCtD
Quinine—Haemorrhage—Carmustine—malignant glioma	0.00199	0.00782	CcSEcCtD
Quinine—Haemoglobin—Temozolomide—malignant glioma	0.00193	0.00759	CcSEcCtD
Quinine—Haemorrhage—Temozolomide—malignant glioma	0.00192	0.00756	CcSEcCtD
Quinine—Hepatitis—Temozolomide—malignant glioma	0.00192	0.00756	CcSEcCtD
Quinine—Visual impairment—Carmustine—malignant glioma	0.00192	0.00754	CcSEcCtD
Quinine—Urinary tract disorder—Temozolomide—malignant glioma	0.0019	0.00746	CcSEcCtD
Quinine—Urethral disorder—Temozolomide—malignant glioma	0.00188	0.00741	CcSEcCtD
Quinine—Eye disorder—Carmustine—malignant glioma	0.00186	0.00731	CcSEcCtD
Quinine—Visual impairment—Temozolomide—malignant glioma	0.00185	0.00728	CcSEcCtD
Quinine—Flushing—Carmustine—malignant glioma	0.00185	0.00726	CcSEcCtD
Quinine—Erythema multiforme—Temozolomide—malignant glioma	0.00182	0.00714	CcSEcCtD
Quinine—Eye disorder—Temozolomide—malignant glioma	0.0018	0.00706	CcSEcCtD
Quinine—Tinnitus—Temozolomide—malignant glioma	0.00179	0.00705	CcSEcCtD
Quinine—Flushing—Temozolomide—malignant glioma	0.00178	0.00701	CcSEcCtD
Quinine—Cardiac disorder—Temozolomide—malignant glioma	0.00178	0.00701	CcSEcCtD
Quinine—Mental disorder—Carmustine—malignant glioma	0.00174	0.00685	CcSEcCtD
Quinine—Immune system disorder—Temozolomide—malignant glioma	0.00174	0.00683	CcSEcCtD
Quinine—Mediastinal disorder—Temozolomide—malignant glioma	0.00173	0.00681	CcSEcCtD
Quinine—Malnutrition—Carmustine—malignant glioma	0.00173	0.00681	CcSEcCtD
Quinine—Erythema—Carmustine—malignant glioma	0.00173	0.00681	CcSEcCtD
Quinine—Chills—Temozolomide—malignant glioma	0.00172	0.00678	CcSEcCtD
Quinine—Mental disorder—Temozolomide—malignant glioma	0.00168	0.00662	CcSEcCtD
Quinine—Erythema—Temozolomide—malignant glioma	0.00167	0.00658	CcSEcCtD
Quinine—Malnutrition—Temozolomide—malignant glioma	0.00167	0.00658	CcSEcCtD
Quinine—Vision blurred—Carmustine—malignant glioma	0.00163	0.00641	CcSEcCtD
Quinine—Tremor—Carmustine—malignant glioma	0.00162	0.00638	CcSEcCtD
Quinine—Agitation—Carmustine—malignant glioma	0.00159	0.00626	CcSEcCtD
Quinine—Vision blurred—Temozolomide—malignant glioma	0.00158	0.0062	CcSEcCtD
Quinine—Tremor—Temozolomide—malignant glioma	0.00157	0.00616	CcSEcCtD
Quinine—Leukopenia—Carmustine—malignant glioma	0.00155	0.00609	CcSEcCtD
Quinine—Agitation—Temozolomide—malignant glioma	0.00154	0.00604	CcSEcCtD
Quinine—Angioedema—Temozolomide—malignant glioma	0.00153	0.00601	CcSEcCtD
Quinine—Vertigo—Temozolomide—malignant glioma	0.0015	0.00591	CcSEcCtD
Quinine—Convulsion—Carmustine—malignant glioma	0.0015	0.0059	CcSEcCtD
Quinine—Leukopenia—Temozolomide—malignant glioma	0.0015	0.00589	CcSEcCtD
Quinine—Palpitations—Temozolomide—malignant glioma	0.00148	0.00581	CcSEcCtD
Quinine—Myalgia—Carmustine—malignant glioma	0.00147	0.00579	CcSEcCtD
Quinine—Chest pain—Carmustine—malignant glioma	0.00147	0.00579	CcSEcCtD
Quinine—Convulsion—Temozolomide—malignant glioma	0.00145	0.0057	CcSEcCtD
Quinine—Confusional state—Carmustine—malignant glioma	0.00142	0.0056	CcSEcCtD
Quinine—Myalgia—Temozolomide—malignant glioma	0.00142	0.0056	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00141	0.00556	CcSEcCtD
Quinine—Oedema—Carmustine—malignant glioma	0.00141	0.00556	CcSEcCtD
Quinine—Thrombocytopenia—Carmustine—malignant glioma	0.00138	0.00544	CcSEcCtD
Quinine—Tachycardia—Carmustine—malignant glioma	0.00138	0.00542	CcSEcCtD
Quinine—Confusional state—Temozolomide—malignant glioma	0.00138	0.00541	CcSEcCtD
Quinine—Oedema—Temozolomide—malignant glioma	0.00136	0.00537	CcSEcCtD
Quinine—Anorexia—Carmustine—malignant glioma	0.00135	0.0053	CcSEcCtD
Quinine—Nervous system disorder—Temozolomide—malignant glioma	0.00134	0.00526	CcSEcCtD
Quinine—Thrombocytopenia—Temozolomide—malignant glioma	0.00134	0.00526	CcSEcCtD
Quinine—Skin disorder—Temozolomide—malignant glioma	0.00133	0.00521	CcSEcCtD
Quinine—Hypotension—Carmustine—malignant glioma	0.00132	0.00519	CcSEcCtD
Quinine—Hyperhidrosis—Temozolomide—malignant glioma	0.00132	0.00519	CcSEcCtD
Quinine—Anorexia—Temozolomide—malignant glioma	0.0013	0.00512	CcSEcCtD
Quinine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00129	0.00506	CcSEcCtD
Quinine—Dyspnoea—Carmustine—malignant glioma	0.00126	0.00495	CcSEcCtD
Quinine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00124	0.00489	CcSEcCtD
Quinine—Decreased appetite—Carmustine—malignant glioma	0.00123	0.00483	CcSEcCtD
Quinine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00122	0.0048	CcSEcCtD
Quinine—Dyspnoea—Temozolomide—malignant glioma	0.00122	0.00479	CcSEcCtD
Quinine—Decreased appetite—Temozolomide—malignant glioma	0.00119	0.00467	CcSEcCtD
Quinine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00118	0.00463	CcSEcCtD
Quinine—Feeling abnormal—Carmustine—malignant glioma	0.00116	0.00458	CcSEcCtD
Quinine—Gastrointestinal pain—Carmustine—malignant glioma	0.00115	0.00454	CcSEcCtD
Quinine—Feeling abnormal—Temozolomide—malignant glioma	0.00112	0.00442	CcSEcCtD
Quinine—Abdominal pain—Carmustine—malignant glioma	0.00112	0.00439	CcSEcCtD
Quinine—Body temperature increased—Carmustine—malignant glioma	0.00112	0.00439	CcSEcCtD
Quinine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00112	0.00439	CcSEcCtD
Quinine—Urticaria—Temozolomide—malignant glioma	0.00108	0.00426	CcSEcCtD
Quinine—Abdominal pain—Temozolomide—malignant glioma	0.00108	0.00424	CcSEcCtD
Quinine—Body temperature increased—Temozolomide—malignant glioma	0.00108	0.00424	CcSEcCtD
Quinine—Hypersensitivity—Carmustine—malignant glioma	0.00104	0.00409	CcSEcCtD
Quinine—Asthenia—Carmustine—malignant glioma	0.00101	0.00399	CcSEcCtD
Quinine—Hypersensitivity—Temozolomide—malignant glioma	0.00101	0.00396	CcSEcCtD
Quinine—Asthenia—Temozolomide—malignant glioma	0.000979	0.00385	CcSEcCtD
Quinine—Diarrhoea—Carmustine—malignant glioma	0.000966	0.0038	CcSEcCtD
Quinine—Pruritus—Temozolomide—malignant glioma	0.000966	0.0038	CcSEcCtD
Quinine—Dizziness—Carmustine—malignant glioma	0.000934	0.00367	CcSEcCtD
Quinine—Diarrhoea—Temozolomide—malignant glioma	0.000934	0.00367	CcSEcCtD
Quinine—Dizziness—Temozolomide—malignant glioma	0.000903	0.00355	CcSEcCtD
Quinine—Vomiting—Carmustine—malignant glioma	0.000898	0.00353	CcSEcCtD
Quinine—Rash—Carmustine—malignant glioma	0.000891	0.0035	CcSEcCtD
Quinine—Dermatitis—Carmustine—malignant glioma	0.00089	0.0035	CcSEcCtD
Quinine—Headache—Carmustine—malignant glioma	0.000885	0.00348	CcSEcCtD
Quinine—Vomiting—Temozolomide—malignant glioma	0.000868	0.00341	CcSEcCtD
Quinine—Rash—Temozolomide—malignant glioma	0.000861	0.00338	CcSEcCtD
Quinine—Dermatitis—Temozolomide—malignant glioma	0.00086	0.00338	CcSEcCtD
Quinine—Headache—Temozolomide—malignant glioma	0.000855	0.00336	CcSEcCtD
Quinine—Nausea—Carmustine—malignant glioma	0.000839	0.0033	CcSEcCtD
Quinine—Nausea—Temozolomide—malignant glioma	0.000811	0.00319	CcSEcCtD
Quinine—CYP2E1—Metabolism—GSTP1—malignant glioma	2.79e-05	7.37e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GSTP1—malignant glioma	2.78e-05	7.35e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	2.78e-05	7.35e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CAT—malignant glioma	2.71e-05	7.17e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CAT—malignant glioma	2.71e-05	7.15e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—BCHE—malignant glioma	2.7e-05	7.14e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—CAV1—malignant glioma	2.68e-05	7.09e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MMP3—malignant glioma	2.68e-05	7.08e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTGS1—malignant glioma	2.68e-05	7.07e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	2.67e-05	7.06e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.67e-05	7.06e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.67e-05	7.05e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.66e-05	7.03e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	2.66e-05	7.01e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTGS1—malignant glioma	2.65e-05	7.01e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.64e-05	6.98e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—BCHE—malignant glioma	2.64e-05	6.97e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GSTP1—malignant glioma	2.63e-05	6.95e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.63e-05	6.94e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CG—malignant glioma	2.62e-05	6.93e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—SLC5A5—malignant glioma	2.61e-05	6.89e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PTK2—malignant glioma	2.58e-05	6.81e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.57e-05	6.79e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	2.57e-05	6.78e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CB—malignant glioma	2.57e-05	6.78e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—NCOR1—malignant glioma	2.56e-05	6.77e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—CAT—malignant glioma	2.56e-05	6.76e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—NCOR1—malignant glioma	2.56e-05	6.76e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PTGS2—malignant glioma	2.54e-05	6.71e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PPARG—malignant glioma	2.54e-05	6.7e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HES1—malignant glioma	2.53e-05	6.69e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PPARG—malignant glioma	2.53e-05	6.69e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.53e-05	6.67e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NCOR1—malignant glioma	2.52e-05	6.65e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.5e-05	6.61e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—BCHE—malignant glioma	2.49e-05	6.57e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—RAF1—malignant glioma	2.48e-05	6.56e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.48e-05	6.55e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—BCHE—malignant glioma	2.47e-05	6.51e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.46e-05	6.49e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—IL2—malignant glioma	2.45e-05	6.48e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.45e-05	6.46e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CG—malignant glioma	2.45e-05	6.46e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.44e-05	6.43e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—IDH1—malignant glioma	2.43e-05	6.43e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	2.43e-05	6.41e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTT1—malignant glioma	2.42e-05	6.39e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—NCOR1—malignant glioma	2.42e-05	6.38e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	2.41e-05	6.37e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTP1—malignant glioma	2.41e-05	6.37e-05	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.4e-05	6.34e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PPARG—malignant glioma	2.36e-05	6.23e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SPHK1—malignant glioma	2.36e-05	6.22e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CAT—malignant glioma	2.35e-05	6.2e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—SPP1—malignant glioma	2.34e-05	6.18e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	2.33e-05	6.16e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.31e-05	6.1e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.31e-05	6.1e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CD—malignant glioma	2.31e-05	6.09e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.3e-05	6.08e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.28e-05	6.03e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTGS1—malignant glioma	2.27e-05	5.99e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.26e-05	5.96e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL2—malignant glioma	2.23e-05	5.88e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TERT—malignant glioma	2.22e-05	5.86e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PTEN—malignant glioma	2.22e-05	5.85e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—NCOR1—malignant glioma	2.22e-05	5.85e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.18e-05	5.77e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PDGFB—malignant glioma	2.17e-05	5.72e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FGFR1—malignant glioma	2.16e-05	5.69e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTP1—malignant glioma	2.15e-05	5.68e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CD—malignant glioma	2.15e-05	5.68e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HIF1A—malignant glioma	2.12e-05	5.61e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—BCHE—malignant glioma	2.11e-05	5.57e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTP1—malignant glioma	2.1e-05	5.55e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CAT—malignant glioma	2.09e-05	5.53e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CAV1—malignant glioma	2.09e-05	5.52e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CAV1—malignant glioma	2.08e-05	5.51e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.08e-05	5.5e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CAV1—malignant glioma	2.05e-05	5.42e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CAT—malignant glioma	2.04e-05	5.4e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KDR—malignant glioma	2.03e-05	5.36e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.01e-05	5.32e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CB—malignant glioma	2.01e-05	5.31e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTGS2—malignant glioma	1.99e-05	5.27e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTGS2—malignant glioma	1.99e-05	5.26e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.99e-05	5.26e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTP1—malignant glioma	1.98e-05	5.23e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—NCOR1—malignant glioma	1.98e-05	5.22e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—CAV1—malignant glioma	1.97e-05	5.2e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.97e-05	5.2e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTP1—malignant glioma	1.96e-05	5.18e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—F2—malignant glioma	1.95e-05	5.16e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FN1—malignant glioma	1.95e-05	5.16e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.95e-05	5.15e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—BAD—malignant glioma	1.93e-05	5.1e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—NCOR1—malignant glioma	1.93e-05	5.1e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CAT—malignant glioma	1.93e-05	5.09e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	1.91e-05	5.05e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CAT—malignant glioma	1.91e-05	5.04e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CG—malignant glioma	1.9e-05	5.03e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.9e-05	5.02e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.88e-05	4.97e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CD80—malignant glioma	1.87e-05	4.95e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CB—malignant glioma	1.87e-05	4.95e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—APC—malignant glioma	1.87e-05	4.94e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	1.87e-05	4.94e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTT1—malignant glioma	1.87e-05	4.93e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTGS2—malignant glioma	1.86e-05	4.9e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EGF—malignant glioma	1.85e-05	4.88e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	1.84e-05	4.85e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PPARG—malignant glioma	1.84e-05	4.85e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PPARG—malignant glioma	1.83e-05	4.84e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—NCOR1—malignant glioma	1.82e-05	4.8e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CAV1—malignant glioma	1.81e-05	4.77e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—NCOR1—malignant glioma	1.8e-05	4.76e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CG—malignant glioma	1.79e-05	4.74e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—BRAF—malignant glioma	1.76e-05	4.64e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTGS1—malignant glioma	1.75e-05	4.62e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTEN—malignant glioma	1.74e-05	4.59e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTEN—malignant glioma	1.74e-05	4.59e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PPARG—malignant glioma	1.73e-05	4.57e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.73e-05	4.56e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—AKT2—malignant glioma	1.71e-05	4.52e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	1.7e-05	4.5e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.7e-05	4.49e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTP1—malignant glioma	1.68e-05	4.43e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CD—malignant glioma	1.67e-05	4.42e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.67e-05	4.41e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.64e-05	4.34e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	1.64e-05	4.34e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CAT—malignant glioma	1.63e-05	4.31e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	1.63e-05	4.3e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—BCHE—malignant glioma	1.63e-05	4.3e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTEN—malignant glioma	1.62e-05	4.28e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CAV1—malignant glioma	1.61e-05	4.26e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	1.61e-05	4.25e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.61e-05	4.24e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PPARG—malignant glioma	1.59e-05	4.19e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.58e-05	4.17e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FGF2—malignant glioma	1.57e-05	4.16e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CAV1—malignant glioma	1.57e-05	4.16e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CA—malignant glioma	1.56e-05	4.13e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—NCOR1—malignant glioma	1.54e-05	4.07e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.54e-05	4.07e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CAV1—malignant glioma	1.48e-05	3.92e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	1.48e-05	3.91e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MDM2—malignant glioma	1.47e-05	3.89e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CAV1—malignant glioma	1.47e-05	3.88e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.47e-05	3.88e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RAF1—malignant glioma	1.47e-05	3.88e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CB—malignant glioma	1.46e-05	3.85e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.46e-05	3.84e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	1.45e-05	3.84e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.45e-05	3.82e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTGS2—malignant glioma	1.44e-05	3.82e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTGS2—malignant glioma	1.44e-05	3.81e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CG—malignant glioma	1.43e-05	3.79e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	1.43e-05	3.79e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PPARG—malignant glioma	1.42e-05	3.74e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.4e-05	3.71e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PPARG—malignant glioma	1.38e-05	3.65e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	1.38e-05	3.64e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.37e-05	3.63e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTGS2—malignant glioma	1.36e-05	3.6e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.35e-05	3.57e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.34e-05	3.54e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	1.33e-05	3.51e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CASP3—malignant glioma	1.32e-05	3.48e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL2—malignant glioma	1.32e-05	3.48e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PPARG—malignant glioma	1.3e-05	3.44e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTP1—malignant glioma	1.29e-05	3.42e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PPARG—malignant glioma	1.29e-05	3.41e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.29e-05	3.41e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—AKT1—malignant glioma	1.28e-05	3.37e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.26e-05	3.33e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTEN—malignant glioma	1.26e-05	3.33e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CD—malignant glioma	1.26e-05	3.33e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CAT—malignant glioma	1.26e-05	3.33e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTEN—malignant glioma	1.26e-05	3.32e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CAV1—malignant glioma	1.26e-05	3.32e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTGS2—malignant glioma	1.25e-05	3.3e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MMP9—malignant glioma	1.25e-05	3.29e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PTEN—malignant glioma	1.24e-05	3.27e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.23e-05	3.24e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CA—malignant glioma	1.23e-05	3.24e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	1.21e-05	3.19e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.2e-05	3.17e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.19e-05	3.14e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTEN—malignant glioma	1.19e-05	3.14e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.19e-05	3.14e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.18e-05	3.11e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.14e-05	3.02e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CA—malignant glioma	1.14e-05	3.02e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.13e-05	2.97e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	1.12e-05	2.95e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTGS2—malignant glioma	1.11e-05	2.94e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—STAT3—malignant glioma	1.11e-05	2.93e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PPARG—malignant glioma	1.1e-05	2.92e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CB—malignant glioma	1.1e-05	2.9e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTEN—malignant glioma	1.09e-05	2.88e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTGS2—malignant glioma	1.09e-05	2.87e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.03e-05	2.73e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MYC—malignant glioma	1.03e-05	2.72e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.03e-05	2.71e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTGS2—malignant glioma	1.03e-05	2.71e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTGS2—malignant glioma	1.02e-05	2.68e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EGFR—malignant glioma	1.01e-05	2.66e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.01e-05	2.66e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—AKT1—malignant glioma	1e-05	2.65e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—AKT1—malignant glioma	1e-05	2.64e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTEN—malignant glioma	9.72e-06	2.57e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CAV1—malignant glioma	9.69e-06	2.56e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KRAS—malignant glioma	9.51e-06	2.51e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTEN—malignant glioma	9.49e-06	2.51e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—AKT1—malignant glioma	9.33e-06	2.46e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTEN—malignant glioma	8.94e-06	2.36e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CA—malignant glioma	8.89e-06	2.35e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CA—malignant glioma	8.87e-06	2.34e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTEN—malignant glioma	8.86e-06	2.34e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CG—malignant glioma	8.83e-06	2.33e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CB—malignant glioma	8.77e-06	2.32e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	8.74e-06	2.31e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTGS2—malignant glioma	8.69e-06	2.29e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PPARG—malignant glioma	8.52e-06	2.25e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TP53—malignant glioma	8.45e-06	2.23e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CA—malignant glioma	8.38e-06	2.21e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.76e-06	2.05e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CA—malignant glioma	7.68e-06	2.03e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTEN—malignant glioma	7.58e-06	2e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—AKT1—malignant glioma	7.26e-06	1.92e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—AKT1—malignant glioma	7.25e-06	1.91e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—AKT1—malignant glioma	7.14e-06	1.88e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CA—malignant glioma	6.86e-06	1.81e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—AKT1—malignant glioma	6.85e-06	1.81e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.77e-06	1.79e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTGS2—malignant glioma	6.7e-06	1.77e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CA—malignant glioma	6.69e-06	1.77e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CA—malignant glioma	6.31e-06	1.67e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—AKT1—malignant glioma	6.28e-06	1.66e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.25e-06	1.65e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTEN—malignant glioma	5.85e-06	1.54e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—AKT1—malignant glioma	5.6e-06	1.48e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—AKT1—malignant glioma	5.47e-06	1.44e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.34e-06	1.41e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—AKT1—malignant glioma	5.15e-06	1.36e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—AKT1—malignant glioma	5.11e-06	1.35e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—AKT1—malignant glioma	4.37e-06	1.15e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.12e-06	1.09e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—AKT1—malignant glioma	3.37e-06	8.9e-06	CbGpPWpGaD
